GH R&D to Revenue
Guardant Health Inc · R&D to Revenue
GH R&D to Revenue
Latest reported37.09%period ending
GH FY R&D/Revenue (43.01% → 37.09%)
Latest values, visible window
High-resolution chart · PNG
GH r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 37.0859% | |
| 47.0562% | |
| 65.1113% | |
| 83.1536% | |
| 70.4453% | |
| 52.2659% | |
| 40.2528% | |
| 55.9516% | |
| 51.2861% | |
| 43.0076% |